Teriflunomide

Basic Information

Item Value
DrugBank ID DB08880
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 41

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 relapsing-remitting multiple sclerosis KG + DL
2 marcothrombocytopenia with mitral valve insufficiency KG + DL
3 hereditary thrombocytopenia with normal platelets KG + DL
4 transient neonatal thrombocytopenia KG + DL
5 thrombocytopenia KG + DL
6 dense granule disease KG + DL
7 penile fibromatosis KG + DL
8 Ledderhose disease KG + DL
9 chronic hepatitis C virus infection KG + DL
10 palmar fibromatosis KG + DL
11 CMM7 KG + DL
12 pediatric leptomeningeal melanoma KG + DL
13 melanoma KG + DL
14 epithelioid cell uveal melanoma KG + DL
15 progressive relapsing multiple sclerosis KG + DL
16 colonic neoplasm KG + DL
17 infantile digital fibromatosis KG + DL
18 cecum villous adenoma KG + DL
19 rectosigmoid junction neoplasm KG + DL
20 cecum neuroendocrine tumor G1 KG + DL
21 cecal disease KG + DL
22 lipoma of colon KG + DL
23 colon leiomyoma KG + DL
24 colonic lymphangioma KG + DL
25 benign neoplasm of cecum KG + DL
26 cavernous hemangioma of colon KG + DL
27 HIV infectious disease KG + DL
28 bronchitis KG + DL
29 vulvar melanoma (disease) KG + DL
30 familial Dupuytren contracture KG + DL
31 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter KG + DL
32 simian immunodeficiency virus infection KG + DL
33 feline acquired immunodeficiency syndrome KG + DL
34 intellectual disability, autosomal dominant 55, with seizures KG + DL
35 platelet storage pool deficiency KG + DL
36 bronchial neoplasm (disease) KG + DL
37 central nervous system melanocytic neoplasm KG + DL
38 plasma cell myeloma KG + DL
39 carotid artery thrombosis KG + DL
40 hepatitis B virus infection KG + DL
41 cyclic hematopoiesis KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.